Evidence map›Paper›PMID 35445468›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

A novel desmoplakin mutation causes dilated cardiomyopathy with palmoplantar keratoderma as an early clinical sign.

V Karvonen, L Harjama, K Heliö, K Kettunen, O Elomaa, J W Koskenvuo, J Kere, S Weckström, M Holmström, J Saarela and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. A frameshift variation in theFrontiers in medicine · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

V Karvonen *Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
L Harjama *Department of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID https://orcid.org/0000-0003-3623-2359
K HeliöDepartment of Cardiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
K KettunenHUS Diagnostic Center, Division of Genetics and Clinical Pharmacology, Laboratory of Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
O ElomaaFolkhälsan Research Center, Helsinki, Finland and Research Programs Unit, Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
J W KoskenvuoBlueprint Genetics, Espoo, Finland.
J KereFolkhälsan Research Center, Helsinki, Finland and Research Programs Unit, Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
S WeckströmDepartment of Cardiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
M HolmströmRadiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
J SaarelaHUS Diagnostic Center, Division of Genetics and Clinical Pharmacology, Laboratory of Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
A RankiDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
T HeliöDepartment of Cardiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
K Hannula-JouppiDepartment of Dermatology and Allergology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
University of Helsinki · FIBlueprint Genetics (Finland) · FI

Funding

Aarne Koskelo FoundationHelsinki University Hospital (HUS) research funds (TYH2018221, TYH2020210, Y2020SK004, Y1016SK004, TYH2021105, Y780021046, Y780020063)Jane and Aatos Erkko FoundationSwedish Psoriasis FoundationThe Emil Aaltonen foundationThe Finnish Cultural FoundationThe Finnish Dermatological Society (SILY)The Finnish Foundation for Cardiovascular ResearchThe Finnish Medical FoundationThe Sigrid Jusélius FoundationThe Swedish Research Council
6 · The paper itself

Abstract

backgroundPPKs represent a heterogeneous group of disorders with hyperkeratosis of palmar and/or plantar skin. PPK, hair shaft abnormalities, cardiomyopathy and arrhythmias can be caused by mutations in desmosomal genes, e.g. desmoplakin (DSP). PPK should trigger genetic testing to reveal mutations with possible related cardiac disease.

objectivesTo report a large multigenerational family with a novel DSP mutation associated with early-onset PPK and adult-onset cardiomyopathy and arrhythmias.

methodsA custom-designed in-house panel of 35 PPK related genes was used to screen mutations in the index patient with focal PPK. The identified DSP mutation was verified by Sanger sequencing. DNA samples from 20 members of the large multigenerational family were sequenced for the DSP mutation. Medical records were reviewed. Clinical dermatological evaluation was performed, including light microscopy of hair samples. Cardiac evaluation included clinical examination, echocardiography, cardiac magnetic resonance imaging (CMR), electrocardiogram (ECG), Holter monitoring and laboratory tests.

resultsWe identified a novel autosomal dominant truncating DSP c.2493delA p.(Glu831Aspfs*33) mutation associated with dilated cardiomyopathy (DCM) with arrhythmia susceptibility and focal PPK as an early cutaneous sign. The mutation was found in nine affected family members, but not in any unaffected members. Onset of dermatological findings preceded cardiac symptoms which were variable and occurred at adult age.

conclusionsWe report a novel truncating DSP mutation causing focal PPK with varying severity and left ventricular dilatation and ventricular extrasystoles. This finding emphasizes the importance of genetic diagnosis in patients with PPK for clinical counselling and management of cardiomyopathies and arrhythmias.

Indexed as

CardiomyopathiesCardiomyopathy, DilatedDesmoplakinsKeratoderma, PalmoplantarAdultHumansMutationDesmoplakinsDSP protein, humandilated cardiomyopathygenodermatosisnext-generation sequencingpalmoplantar keratoderma

Identifiers

PMID35445468
PMCPMC9545885
OpenAlexW4224248511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.